• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
  • New
Biologics in Allergic/Immunologic Conditions, An Issue of Immunology and Allergy Clinics of North America

Biologics in Allergic/Immunologic Conditions, An Issue of Immunology and Allergy Clinics of North America

9780443297366
463.63 zł
394.09 zł Save 69.54 zł Tax included
Lowest price within 30 days before promotion: 394.09 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Immunology and Allergy Clinics, guest editor Dr. Flavia Hoyte brings her considerable expertise to the topic of Biologics in Allergic/Immunologic Conditions. Top experts provide an overview of the state of biologic treatments for autoimmune and allergic conditions including asthma, COPD, food allergies, atopic dermatitis; and more.
Product Details
Elsevier
102685
9780443297366
9780443297366

Data sheet

Publication date
2024
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
152 x 229
Weight (g)
450
  • Current and Emerging Biologics for Atopic Dermatitis
    Chronic Spontaneous Urticaria: Current and Emerging Biologic Agents
    Advancements in Biologic Therapies for Eosinophilic Gastrointestinal Diseases: A Comprehensive Review
    Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis
    Biologics in Food Allergies: Emerging Therapies
    Biologics in Chronic Rhinosinusitis: Current and Emerging
    Biologics in Aspirin-Exacerbated Respiratory Disease and Allergic Bronchopulmonary Aspergillosis
    Asthma Biologics: Lung Function, Steroid-Dependence, and Exacerbations
    Biologics in Asthma: Role of Biomarkers
    Biologics in Asthma: Potential to Achieve Clinical Remission
    Real-World Studies of Biologics for the Treatment of Moderate-to-Severe Asthma
    Biologics in Asthma: Emerging Biologics
Comments (0)